| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |